NDC 66302-120

Remodulin

Treprostinil

Remodulin is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by United Therapeutics Corporation. The primary component is Treprostinil.

Product ID66302-120_661b21bb-8386-44ed-8ea4-0c423f1d6d60
NDC66302-120
Product TypeHuman Prescription Drug
Proprietary NameRemodulin
Generic NameTreprostinil
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2022-01-25
Marketing CategoryNDA /
Application NumberNDA021272
Labeler NameUnited Therapeutics Corporation
Substance NameTREPROSTINIL
Active Ingredient Strength400 mg/20mL
Pharm ClassesProstacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 66302-120-01

1 VIAL in 1 BOX (66302-120-01) > 20 mL in 1 VIAL
Marketing Start Date2022-01-25
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Remodulin" or generic name "Treprostinil"

NDCBrand NameGeneric Name
66302-101Remodulintreprostinil
66302-102Remodulintreprostinil
66302-105RemodulinRemodulin
66302-110RemodulinRemodulin
0703-0666TreprostinilTreprostinil
0703-0676TreprostinilTreprostinil
0703-0686TreprostinilTreprostinil
0703-0696TreprostinilTreprostinil
0781-3420Treprostiniltreprostinil
0781-3425Treprostiniltreprostinil
0781-3427Treprostiniltreprostinil
0781-3430Treprostiniltreprostinil
42023-206TreprostinilTreprostinil
42023-207TreprostinilTreprostinil
42023-208TreprostinilTreprostinil
42023-209TreprostinilTreprostinil
62332-514TreprostinilTreprostinil
62332-515TreprostinilTreprostinil
62332-516TreprostinilTreprostinil
62332-517TreprostinilTreprostinil

Trademark Results [Remodulin]

Mark Image

Registration | Serial
Company
Trademark
Application Date
REMODULIN
REMODULIN
76173227 2618835 Live/Registered
United Therapeutics Corporation
2000-11-30
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.